TORINO, Italy--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today that it has entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of PAI ...
(Nanowerk Spotlight) Advanced molecular diagnostics tests that can rapidly and precisely detect diseases within the home could revolutionize preventive medicine and improve global biosecurity. Nucleic ...
TORINO, Italy--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) is pleased to announce the closing of its acquisition of ELITechGroup (“ELITech”) for €870 million in cash, excluding the carved out ...
Strategic Investor, Osang Healthcare will partner with Kryptos Biotechnologies for the manufacturing and distribution of the product along with financing. “We are thrilled to receive the trust and ...
Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...
With infectious diseases, time is of the essence. Doctors can more easily treat and prevent the spread of diseases such as tuberculosis, Ebola and COVID-19 when they can rapidly and accurately ...
QIAGEN Signs Agreement for the Acquisition of eGene Strategic Transaction Adds Capillary Sample Separation Technology VENLO, The Netherlands - QIAGEN N.V., the world's leading provider of sample and ...
BETHESDA, Md. & GAITHERSBURG, Md., July 28, 2025--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback